Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulation
Nature Communications2014Vol. 5(1), pp. 5418–5418
Citations Over TimeTop 10% of 2014 papers
Kyung‐Hyun Park‐Min, Elisha Lim, Min Joon Lee, Sung Ho Park, Ευγενία Γιαννοπούλου, Anna Yarilina, Marjolein C. H. van der Meulen, Baohong Zhao, Nicholas Smithers, Jason Witherington, Kevin Lee, Paul P. Tak, Rab K. Prinjha, Lionel B. Ivashkiv
Related Papers
- → RANKL as the master regulator of osteoclast differentiation(2021)153 cited
- → An inhibitory role for caspase‐3 at the late stage of RANKL‐induced osteoclast differentiation in RAW264 cells and mouse bone marrow macrophages(2014)4 cited
- → The effects of tumor necrosis factor-α on osteoclast formation depend on the haematopoietic precursors(2006)
- 64Cu-RGD and microPET/CT as an imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation(2009)
- → Inhibitory Effect of Agrocybe Chaxingu (Chaxines) on RANKL-Induced Osteoclast Differentiation in RAW246.7 Cells: Possible Prevention of Osteoporosis(2022)